Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-850-2 | CAS number: 133855-98-8 BAS 480 F
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Oct. 1988 - March 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Version / remarks:
- adopted May 26, 1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- EC Number:
- 406-850-2
- EC Name:
- (2RS,3RS)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
- Cas Number:
- 133855-98-8
- Molecular formula:
- C17 H13 Cl F N3 O
- IUPAC Name:
- 1-{[(2R,3R)-3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: CHO cell line, cell bank of CCR
- Suitability of cells: The CHO cell line has been used successfully in in vitro experiments for many years. Especially the high proliferation
rate (doubling time 16 - 20 h in stock cultures) and a high plating efficiency of untreated cells (as a rule more than 50 %) both necessary for the appropriate performance of the study, recommend the use of this cell line.
For cell lines:
- Absence of Mycoplasma contamination: not specified
- Number of passages if applicable: not specified
- Methods for maintenance in cell culture: The cells were subcultured twice weekly. Seeding was done with about 1 x 10^6 cells per flask in 15 mL of DMEM/F12 (mixture 1:1) medium supplemented with 10 % fetal calf serum.
- Doubling time: 16 - 20 h
- Modal number of chromosomes: 20
- Periodically checked for karyotype stability: not specified
MEDIA USED
- Type and composition of media: DMEM/F12 (mixture 1:1) medium supplemented with 10 % fetal calf serum
- CO2 concentration: 11 %
- Humidity level: humdified incubator (not further specified)
- Temperature: 37°C
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : liver of Aroclor 1254-induced Wistar rats
- method of preparation of S9 mix: An appropriate quantity of S9 supernatant was thawed and mixed with S9 cofactor solution to result in a final protein concentration of 0.3 mg/mL in the cultures. The composition of the cofactor solution was concentrated to yield the following concentrations in the S9 mix: 8 mM MgCl2, 33 mM KCl, 5 mM glucose-6-phosphate, 5 mM NADP, in 100 mM sodium-ortho-phosphate-buffer, pH 7.4.
- concentration or volume of S9 mix in the final culture medium: 20 µL/mL
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): the metabolic capability was checked by positive controls - Test concentrations with justification for top dose:
- 7-h interval: 10.0; 50.0; 100.0; 140.0 µg/ml
24-h interval: 1.0; 5.0; 10.0; 50.0; 100.0; 140.0 µg/ml
30-h interval: 10.0; 50.0; 100.0; 140.0 µg/ml
In a pre-experiment for toxicity the colony forming ability of the CHO cells was reduced to about 40 % after treatment with the highest concentration (140.0 µg/mL) in the absence and presence of S9 mix. Higher concentrations precipitated in the culture medium. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen according to its solubility properties and its relative non-toxicity for the cells.
- Percentage of solvent in the final culture medium: The final concentration of the solvents in the culture medium did not exceed 1 % v/v.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments : 1
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): approx. 0.6 - 1.5 x 10^5 cells/chamber
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 4 h
FOR CHROMOSOME ABERRATION AND MICRONUCLEUS:
- Spindle inhibitor (cytogenetic assays): 5, 21 and 27 h after the start of the treatment colcemid was added (0.2 µg/mL culture medium) to the cultures for a duration of 2 h (7 h interval) or 3 h (24 h and 30 h interval).
- Methods of slide preparation and staining technique used including the stain used (for cytogenetic assays): After treatment with the spindle inhibitor, the cells on the slides in the chambers were treated with hypotonic solution (0.4 % KCl) at 37°C for 20 min. Afterwards the cells were fixed with 3:1 absolute methanol:glacial acetic acid. All two slides per group were prepared. After fixation the cells were stained with giemsa.
- Number of cells spread and analysed per concentration (number of replicate cultures and total number of cells scored): At least 100 well spread metaphases per slide (200 per test group) were scored.
- Criteria for scoring chromosome aberrations (selection of analysable cells and aberration identification): Gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations were recorded as structural chromosome aberrations.
- Determination of polyploidy: not specified
- Determination of endoreplication: not specified
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: To describe a cytotoxic effect the mitotic index (% cells in mitosis) was determined. - Evaluation criteria:
- The test article was classified as mutagenic if it induced either a significant dose-related increase in the number of structural chromosomal aberrations or a significant positive response for at least one of the test points.
A test article producing neither a significant dose-related increase in the number of structural chromosomal aberrations nor a significant positive response at any one of the test points was considered non-mutagenic in this system. - Statistics:
- A statistical evaluation of the results was not necessary to perform. The aberration rates of the test groups after treatment with the test article were in the range of the control values.
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: not specified
- Data on osmolality: not specified
- Possibility of evaporation from medium: not specified
- Water solubility: not specified
- Precipitation: Higher concentrations than 140 μg/mL resulted in test substance precipitation.
- Definition of acceptable cells for analysis: Only metaphases with characteristic chromosome number of 20 +/- 1 were included in the analysis.
RANGE-FINDING/SCREENING STUDIES: In the pre-experiment on toxicity (colony forming ability) in the absence and presence of S9 mix treatment the highest concentration (140.0 µg/mL) reduced distinctly the colony forming ability. Higher concentrations precipitated in the culture medium.
STUDY RESULTS
- Concurrent vehicle negative and positive control data : see tables 1 - 3
- Results from cytotoxicity measurements: The mitotic index was reduced by about 60 % after treatment with the highest concentration (140.0 µg/mL) at fixation intervals 7 and 24 h.
- Genotoxicity results
o Definition for chromosome aberrations, including gaps : not specified
o The following dose levels were evaluated: 7-h interval: 140.0 µg/mL; 24-h interval: 10.0, 50.0 and 140 µg/mL; 30-h interval: 140 µg/mL
o Changes in ploidy (polyploidy cells and cells with endoreduplicated chromosomes) if seen : not specified
HISTORICAL CONTROL DATA
- Positive historical control data: not specified
- Negative (solvent/vehicle) historical control data: not specified
Any other information on results incl. tables
Tab. 1: Mutagenicity data (summary of results), fixation interval: 7 h after start of treatment
article | number of cells analysed | conc. per mL | S9 mix | % abberant cells | ||
incl. gaps | excl. gaps | exchanges | ||||
Solvent control | 200 | 0.0 µg | - | 4.00 | 3.00 | 0.50 |
Test article | 200 | 140.0 µg | - | 4.00 | 2.50 | 0.00 |
Solvent control | 200 | 0.0 µg | + | 6.00 | 1.50 | 0.00 |
Test article | 200 | 140.0 µg | + | 8.50 | 1.50 | 0.00 |
Tab. 2: Mutagenicity data (summary of results), fixation interval: 24 h after start of treatment
article | number of cells analysed | conc. per mL | S9 mix | % abberant cells | ||
incl. gaps | excl. gaps | exchanges | ||||
Negative control | 200 | 0.0 µg | - | 4.00 | 2.50 | 1.00 |
Solvent control | 200 | 0.0 µg | - | 1.50 | 1.00 | 0.00 |
Positive control EMS | 200 | 0.72 mg | - | 10.50 | 9.00 | 6.50 |
Test article | 200 | 10.0 µg | - | 0.50 | 0.50 | 0.50 |
Test article | 200 | 50.0 µg | - | 2.00 | 1.50 | 0.00 |
Test article | 200 | 140.0 µg | - | 3.50 | 2.50 | 0.00 |
Negative control | 200 | 0.0 µg | + | 4.00 | 2.50 | 1.00 |
Solvent control | 200 | 0.0 µg | + | 5.50 | 3.50 | 0.50 |
Positive control CPA | 200 | 4.2 µg | + | 20.00 | 17.00 | 10.00 |
Test article | 200 | 10.0 µg | + | 4.00 | 2.50 | 0.50 |
Test article | 200 | 50.0 µg | + | 4.50 | 3.50 | 1.00 |
Test article | 200 | 140.0 µg | + | 5.50 | 3.00 | 1.00 |
Tab. 3: Mutagenicity data (summary of results), fixation interval: 30 h after start of treatment
article | number of cells analysed | conc. per mL | S9 mix | % abberant cells | ||
incl. gaps | excl. gaps | exchanges | ||||
Solvent control | 200 | 0.0 µg | - | 0.50 | 0.50 | 0.00 |
Test article | 200 | 140.0 µg | - | 2.00 | 1.50 | 0.00 |
Solvent control | 200 | 0.0 µg | + | 4.00 | 3.50 | 1.50 |
Test article | 200 | 140.0 µg | + | 2.00 | 1.00 | 0.50 |
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.